Leonide Saad

Leonide Saad

Company: Alkeus

Job title: President & CEO


Targeting the Visual Cycle Through Vitamin A Modification 12:00 pm

Dry AMD treatment with minerals, antioxidants, and other natural compounds. Current challenges and therapeutic approaches for the treatment of Geographic Atrophy: drug delivery, animal models, study designs Visual cycle: to slow or not to slow? Use of ALK-001 as vitamin A replacement therapy for the treatment of dryAMD or Geographic Atrophy Leonide Saad, President &…Read more

day: Track 2 Day 2 AM

Panel Discussion: With Unprecedented Phase III Progress & Expected Regulatory Feedback on Submissions, What Direction is Provided for the Dry AMD/GA Field? 4:45 pm

How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for dry-AMD? Discuss how slow disease progression and a less than ideal endpoint measurement method lead to clinical trials that are necessarily large, lengthy and expensive Examine how innovations in clinical trials with novel…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.